While in highly aggressive prostate cancer, FoxO1 could bind to Twist1 promoter, induce EMT and invasion via AKT/FoxO1/Twist1 pathway.45 This discrepancy might be due to different roles which FoxO1 played in the chosen tumours. This evidence concerns the gene TWIST1 and prostate carcinoma.